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rotid reopening independent of the technique used. Only 
scores on the copy drawing test (visuospatial and construc-
tional abilities) slightly but significantly (p  ! 0.05) worsened 
in the CAS group 12 months after the intervention. No sig-
nificant differences between the CEA and CAS groups were 
detected regarding mood and functional status after 3 and 
12 months.  Conclusions: CEA and CAS seem to be safe pro-
cedures in elderly patients in terms of cognitive, mood and 
functional status in the short and long term. CAS might be 
preferred for the shorter hospital stay, but further studies 
with a larger number of old and oldest old subjects with a 
longer follow-up are needed to better understand the cost-
effectiveness of both treatments. 
 Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Asymptomatic carotid artery stenosis (ACAS) is pres-
ent in up to 12.5% of subjects older than 70 years  [1] , and 
it has been recognized as a risk factor for stroke  [2] and 
cognitive decline  [3] . Stroke is the third leading cause of 
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 Abstract 
 Background: It is still a matter of debate if and to what ex-
tent carotid endarterectomy (CEA) and carotid artery stent-
ing (CAS) impair cognitive functioning in the elderly.  Meth-
ods: We conducted a nonrandomized clinical trial on sub-
jects with asymptomatic carotid artery stenosis comparing 
CEA (n = 28; 24 males and 4 females; 72.6  8 5.8 years old) 
with CAS (n = 29; 17 males and 12 females; 75.1  8 5.7 years 
old). Cognition, mood and functional status were evaluated 
by a broad spectrum of tests performed on the day prior to 
carotid reopening as well as 3 and 12 months after.  Results: 
No significant differences in scores on cognitive tests includ-
ing the Babcock story recall test and Rey’s auditory verbal 
learning test (memory), category naming test (verbal fluen-
cy), trail-making test parts A and B (attention and executive 
function) and controlled oral word association test (execu-
tive functioning) were observed 3 and 12 months after ca-
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death in the USA and Europe  [4] and one of the main 
causes of long-term disability. It has been suggested that 
one in three North Americans will experience stroke, de-
mentia or both during their life  [5] and that after a cere-
brovascular event, 64% of subjects will develop dementia 
 [6] . The risk of incident dementia in the elderly increased 
fourfold after ischemic stroke in cognitively healthy sub-
jects compared to clinically stroke-free controls  [7] .
 A compromised cerebral blood flow plays an impor-
tant role in the recurrence of ischemic episodes, and 
ACAS is recognized as a risk factor for vascular cognitive 
impairment  [8] . While the surgical treatment of carotid 
artery stenosis has been proposed half a century ago to 
reverse cognitive impairment or prevent its progression 
 [9] , the impact of carotid surgery on cognitive function-
ing has recently gained a great deal of attention. This is 
due to the occurrence, especially among the elderly, of 
neurological and cognitive deficits after cardiac and non-
cardiac surgery  [10, 11] .
 Studies on the effects of carotid reopening on cogni-
tion are quite controversial  [12] . While the intervention 
in carotid stenosis might be beneficial by enhancing ce-
rebral perfusion  [9] , a recent review of population-based 
studies has suggested that carotid reopening could also 
lead to cognitive decline through different mechanisms 
 [13] . Carotid reopening can be achieved either by carotid 
endarterectomy (CEA) or carotid artery stenting (CAS). 
A decline in cognitive function after carotid reopening 
could occur from microembolic ischemia during sur-
gical dissection (CEA) or intravascular maneuvering 
(CAS), or from hypoperfusion during clamping (CEA) 
or balloon dilation (CAS). It is still unclear whether the 
carotid revascularization will ultimately result in im-
proving or worsening cognitive functioning. Further-
more, it is unknown whether CEA and CAS have a dif-
ferent effect on cognitive outcomes, especially in the el-
derly, since the clinical investigations designed to 
compare the efficacy of these techniques in patients with 
carotid artery stenosis have mainly focused on classical 
endpoints such as stroke, myocardial infarction and 
death  [14–16] .
 The aim of this study was to investigate the short- and 
long-term impact of CEA and CAS on several cognitive 
functions in elderly subjects who had previously been 
cognitively healthy, and were evaluated by a comprehen-
sive neuropsychological battery before intervention and 
at 3- and 12-month follow-up time points.
 Patients and Methods 
 Patients 
 Elderly patients aged 65 years and over admitted to the Divi-
sion of Vascular Surgery at the University Hospital of Perugia 
from January 2007 to January 2008 with a diagnosis of asymp-
tomatic severe ( 1 70%) internal carotid artery (ICA) stenosis were 
included in the study after having given their informed consent. 
The study was approved by the local ethical committee and con-
forms to the Declaration of Helsinki.
 Exclusion criteria were the presence of dementia diagnosed on 
the basis of DSM-IV  [17] criteria and a Mini-Mental State Exam-
ination (MMSE)  [18] score of  ! 24/30. Other exclusion criteria 
were the presence of depression diagnosed on the basis of DSM-IV 
 [17] criteria, a history of stroke as well as the inability to provide 
consent or compliance with the follow-up procedures.
 Patients underwent full clinical and neuropsychological eval-
uation on the day prior to the carotid reopening procedure (T0) 
and at 3- (T3) and 12-month (T12) follow-up time points by spe-
cifically trained geriatricians (F.T.F., F.M., T.R. and V.C.). Demo-
graphic, clinical and pharmacological data were also collected. 
Major vascular risk factors/diseases were recorded as follows: hy-
pertension (systolic blood pressure  6 140 mm Hg and/or diastol-
ic blood pressure  6 90 mm Hg or use of antihypertensive drugs); 
diabetes (fasting blood glucose  6 126 mg/dl or use of blood-glu-
cose-lowering drugs); hypercholesterolemia (LDL  6 130 mg/dl or 
use of lipid-lowering drugs); hypertriglyceridemia ( 6 200 mg/dl 
or use of specific treatment), and coronary artery disease (previ-
ous history of myocardial infarction or ECG signs of ischemic 
heart disease). 
 Vascular Diagnostics and Operative Procedures 
 The diagnosis of severe stenosis of the ICA was ascertained by 
means of duplex ultrasound performed by independent experi-
enced vascular surgeons, using an ATL HDI 3000 system with a 
12.5-MHz linear probe. Measurements of the site, degree and 
length of stenosis, plaque characteristics and vessel were performed 
in order to select the adequate size of the balloon and stent in case 
of CAS intervention. A stenosis of  1 70% was diagnosed when the 
peak systolic velocity exceeded 200 cm/s. Duplex velocity criteria 
had previously been validated against angiography as a gold stan-
dard using the European Carotid Surgery Trial criteria  [19] . The 
severity of stenosis in the operated carotid ranged from 70 to 90%. 
Stenosis of the contralateral carotid is reported in  table 1 .
 CEA or CAS procedures were selected according to plaque 
morphology and comorbidity. Usually, CAS was preferred in the 
presence of long plaque, severe coronary or pulmonary disease, 
previous neck surgery or irradiation. CEA was chosen when a 
fatty component and/or thrombus within the carotid plaque were 
probable, in addition to the presence of severe carotid tortuosity 
or calcification  [20] . Both types of interventions were performed 
by highly experienced vascular surgeons (P.D.R., P.C.).
 CAS was performed in a dedicated operating room equipped 
for endovascular procedures, under local anesthesia and through 
a femoral approach. Cerebral protection devices and stents of dif-
ferent models were used. CEA was performed under local (15 sub-
jects) or general (7 subjects) anesthesia according to the patients’ 
preferences and vessel anatomy. The patients were continuously 
monitored during the intervention by transcranial Doppler and 
by direct neurological assessment while they were awake  [20] . No 
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complications were observed during the intervention and at the 
follow-up.
 Follow-Up Study 
 The postoperative evaluation consisted of clinical and duplex 
examinations performed by surgeons before discharge and after 
1, 3, 6 and 12 months. A follow-up evaluation of the cognitive sta-
tus was performed by geriatricians 3 months after the revascular-
ization procedure (short-term follow-up) and 12 months later 
(long-term follow-up), using the same battery of tests.
 Neuropsychological and Functional Assessment 
 Neuropsychological tests were administered by a trained phy-
sician who was blind to the operative procedure in a quiet envi-
ronment in the hospital. The battery of tests included the MMSE 
 [18] as measure of global cognitive function and tests evaluating 
the following cognitive domains:
 (1) Memory: Babcock story recall (SR) test and Rey’s auditory ver-
bal learning test, immediate (Rey-IR) and delayed recall (Rey-
DR), to assess episodic memory; verbal fluency with semantic 
cues (category naming test, CNT) to estimate semantic abili-
ties; in order to minimize the learning effect, 3 alternative lists 
of words were used for the Rey 
 (2) Attention and executive functions: trail-making test, part A 
(TMT-A) and B (TMT-B), to evaluate selective and divided 
 attention, respectively; controlled oral word association test 
(COWA) to estimate executive functioning 
 (3) Visuospatial and constructional abilities: copy drawing test 
(CD). 
 Details on the administration procedures and scoring as well 
as the Italian normative data on score adjustment for age and ed-
ucation, and the normality cutoff scores (95% of the lower toler-
ance limit of the normal population distribution) were used for 
each test  [21, 22] .
 At the end of the cognitive session, the presence of depressive 
symptoms was assessed using the 15-item version of the Geriatric 
Depression Scale (GDS)  [23] . Basic activities of daily living (ADL) 
 [24] and instrumental activities of daily living (IADL)  [25] were 
used to examine the functional status.
 Statistical Analysis 
 Data are presented as means  8 SD for continuous variables 
and as proportions for categorical variables. Because of the small 
number of enrolled subjects and nonnormal distribution of sev-
eral of the considered variables, a nonparametric statistic was 
chosen. Comparisons between groups were performed by the 
Mann-Whitney test for independent samples, and by Fisher’s  ! 2 
test as appropriate, while intragroup comparisons at different 
points in time were performed by the Wilcoxon signed-rank test.
 In order to evaluate cognitive functions, and mood and func-
tional status after surgery, the differences observed in each patient 
after 3 months (T3 – T0,  " T3) and 12 months (T12 – T0,  " T12) 
with respect to baseline were computed. For neuropsychological 
tests,  " was calculated from scores adjusted for age and education 
according to the Italian normative data. The mean  " values were 
compared (i) within each treatment group to assess the variation 
over time, and (ii) between groups to detect any different effects 
between CEA or CAS. The data were analyzed using the SPSS sta-
tistical software, version 12.0 (SPSS, Chicago, Ill., USA). The lev-
el of significance was set at p  ! 0.05 for all analyses.
 Results 
 Fifty-seven patients were enrolled in the study. Of 
these, 28 (24 males, 4 females; 72.6  8 5.8 years old) un-
derwent CEA and 29 (17 males, 12 females; 75.1  8 5.7 
years old) underwent CAS. The demographics as well as 
data on frequency of vascular comorbidity and vascular 
risk factors of the 2 groups are shown in  table 1 . No sig-
nificant differences were observed between the groups, 
except for gender composition, since women were repre-
sented more frequently in the CAS than in the CEA 
group (p  ! 0.05). The use of antihypertensive, blood-
glucose-lowering, lipid-lowering, antiplatelet and anti-
coagulant drugs was not different between the groups at 
baseline and at the follow-up evaluations (data not 
shown).
 Among the 28 patients assigned to CEA, 22 completed 
the study. Six subjects declined to be evaluated at follow-
up due to a subsequent diagnosis of cancer (n = 1) and 
Parkinson’s disease (n = 1), while 4 withdrew their con-
sent. Of the 29 patients assigned to CAS, 24 completed the 
study, 5 withdrew due to a subsequent diagnosis of cancer 
(n = 2) and abdominal aneurism (n = 1), or withheld their 
consent (n = 2). In subsequent telephone interviews (at T3 
and T12), no vascular event/death was reported for sub-
jects who interrupted the study.
Table 1.  Demographic and clinical characteristics and vascular 
risk factors in CEA and CAS patients
CEA
(n = 22)
CAS
(n = 24)
p
Age, years 71.985.7 75.685.7 0.19
Range 65482 65488
Gender – female, n 4 (18%) 11 (46%) <0.05
Education, years 8.085.1 5.783.0 0.06
Stenosis of the contralateral carotid, %
Right 53823 49830 0.6
Left 35829 29820 0.5
Vascular risk factors, n
Hypertension 20 (90.0%) 17 (71.0%) 0.1
Diabetes 7 (32.0%) 9 (37.5%) 0.6
Hypercholesterolemia 13 (59.1%) 11 (45.8%) 0.3
Hypertriglyceridemia 5 (27.0%) 6 (25.0%) 0.8
Coronary artery disease 5 (23.0%) 6 (25.0%) 0.8
Atrial fibrillation 1 (4.5%) 2 (4.2%) 0.9
Smoking habit –
current smokers 6 (27%) 5 (21%) 0.6
Values are means 8 SD, unless specified otherwise.
 CEA, Stenting and Cognition Cerebrovasc Dis 2010;30:244–251  247
 Cognitive Performance between Groups (CAS and CEA) 
 The cognitive test scores, functional scale scores and 
GDS scores at T0, T3 and T12 are reported in  table 2 . No 
significant differences were observed at T0, T3 and T12 
between CEA or CAS patients, excluding the TMT-A, in 
which the mean score observed in the CEA group was 
lower (i.e. better) at T3 and T12 compared to the CAS 
group. However, patients undergoing CEA showed a non-
significantly better performance than patients undergo-
ing CAS in the TMT-A at T0 as well (p = 0.058).
 Cognitive Changes over Time within Groups
(CEA or CAS) 
 Within each group, the variations over time in mean 
cognitive test scores (i.e.  " T3 vs.  " T12 in the CEA group, 
 " T3 vs.  " T12 in the CAS group) were not significant, 
with the exception of the visuospatial and constructional 
abilities (CD), which slightly worsened in the CAS group 
( " T3 vs.  " T12 on the CD; p  ! 0.05) ( table 3 ). No signifi-
cant differences were detected in functional abilities and 
mood status.
 Cognitive Changes over Time between Groups
(CEA versus CAS) 
 When assessing the presence of a different effect be-
tween the 2 surgical approaches on cognitive perfor-
mance over time (i.e.  " T3 CEA vs.  " T3 CAS,  " T12 CEA 
vs.  " T12 CAS), no significant differences were detected 
( table 3 ). Furthermore, no significant differences were de-
tected for functional abilities and  mood. 
 Discussion 
 Notwithstanding a slight deterioration over time in vi-
suospatial and constructional abilities in the CAS group, 
the main result of this study is that neither CEA nor CAS 
appears to significantly affect cognitive functioning in 
elderly patients three or twelve months after carotid re-
vascularization.
 Cognitive impairment has been reported to be one of 
the earliest and most common manifestations of cerebro-
vascular disease, and it has been proposed that cognitive 
Table 2.  Neuropsychological characteristics of CEA and CAS patients at T0, T3 and T12
CEA (n = 22) C AS (n = 24)
T0 T3 T12 T0 T3 T12
Global cognition
MMSE 27.882.3 27.482.4 27.683.0 27.281.9 26.582.8 27.782.1
Functional scales
ADL 5.980.4 5.780.6 5.780.5 5.780.5 5.480.5 5.680.5
IADL 5.681.7 5.682.0 6.081.7 5.982.1 6.281.4 6.282.0
Mood
GDS 3.081.5 2.381.9 2.281.7 4.482.4 2.981.9 4.183.9
Memory
Babcock SR 9.183.1 10.683.0 9.784.0 9.083.1 8.583.6 9.582.4
Rey-IR 33.587.0 33.987.8 35.286.7 35.588.9 34.7810.2 34.686.1
Rey-DR 8.783.8 7.382.4 7.883.0 7.484.0 6.982.1 7.781.9
CNT 14.384.7 16.085.6 13.184.5 14.384.0 15.284.7 13.684.0
Attention and executive functioning
TMT-A, s 52.9824.4 63.2850a 55.6822.5b 74.1837.7 109.2874.4 97.2851.0
TMT-B, s 162.58108.5 154.98127.5 134.6892.3 135.4878.5 123.7899.6 118.38145.2
COWA 22.489.1 25.7811.8 28.0812.2 22.787.8 25.387.9 24.088.7
Visuospatial and constructional abilities
CD 12.581.7 12.181.6 11.582.4 12.582.0 13.181.4 12.081.9
Val ues are presented as means 8 SD. a p < 0.05, b p < 0.01 versus CAS. MMSE score ranging from 0 (worst) to 30 (best); ADL score 
ranging from 0 (worst) to 6 (best); IADL score ranging from 0 (worst) to 8 (best).
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testing could be a particularly sensitive outcome measure 
in primary or secondary prevention studies  [6] .
 If cognitive decline is a clinical manifestation of cere-
brovascular disease related to ICA, cognitive assessment 
will represent a useful tool for exploring the functional 
outcome of carotid revascularization procedures  [26] . 
This has prompted studies in the field, but few have been 
performed on the elderly, the population more at risk of 
cognitive decline and dementia  [27] , and so far both CEA 
and CAS have not shown any clear effects on cognitive 
endpoints.
 Although previous reports in this field found an im-
provement after CEA, more recent studies have consis-
tently demonstrated no change or even cognitive decline 
 [28] . The major points of criticism of the studies on cog-
nitive performance after CEA or CAS include contrasting 
approaches regarding the assessment timing, typology of 
cognitive tests, extent of follow-up, number of enrolled 
patients, lack of a control population, and severity of ste-
nosis  [13, 28] .
 Carotid revascularization is recognizably exposed to 
show an increased risk of cerebral embolization or silent 
microembolization with uncertain but potential negative 
effects on cognition. Therefore, the supposed benefit of a 
restored cerebral perfusion to cognitive performance  [9] 
is opposed by the potential harm of microembolic lesions 
occurring during CEA or CAS that could lead to cogni-
tive impairment. However, there is no proof of such a 
link, and over the past decades, conflicting effects of mi-
croembolisms on cognition have been found during ca-
rotid vascularization  [28] . 
 CAS is a rapidly evolving technique, and technological 
advances such as the use of embolic protection devices as 
well as improvements in the experience of operators (spe-
cific training and appropriate learning curve) have sig-
nificantly reduced the rate of adverse events  [29] . Thus, 
in the past few years, CAS has been used increasingly of-
ten despite the negative results of some published ran-
domized clinical trials  [14–16, 30–32] . Although some re-
cent, large case-series registries have indicated that CAS 
can be performed at acceptable complication rates, a high 
incidence of emboli shed to the brain has generated great 
concern regarding the safety of this technique, especially 
when considering the established low risk and durability 
of CEA  [30–34] . In fact, higher embolization rates during 
CAS compared to surgery have been reported using ei-
ther transcranial Doppler sonography to monitor micro-
embolic events or applying diffusion-weighted imaging 
(DWI) to detect new embolic brain lesions after the inter-
vention  [20, 30, 32, 35] .
 Recently, the International Carotid Stenting Study 
showed that the risk of microembolism is threefold in-
creased during CAS compared to CEA for patients with 
symptomatic carotid stenosis according to DWI MRI 
CEA "T3 CEA "T12 CAS "T3 CAS "T12
Global cognition
MMSE –0.5282.5 –0.0382.5 –0.5383.1 0.1382.7
Functional scales
ADL –0.1580.60 –0.1080.47 –0.1680.51 –0.0680.5
IADL –0.1582.2 0.3782.0 0.3882.1 0.0682.0
Mood
GDS –0.682.0 –0.881.7 –1.082.1 –0.283.9
Memory
Babcock SR 1.483.9 0.385.0 –0.284.5 –0.483.3
Rey-IR –1.586.3 1.686.2 –0.5812.0 –1.589.2
Rey-DR –1.984.8 –0.984.6 –0.182.6 –0.682.4
CNT 1.287.1 –1.484.5 0.885.8 –1.983.5
Attention and executive functioning
TMT-A, s 12.7857.5 –0.1828.2 30.7865.2 21.5859.1
TMT-B, s –3.2898.3 –49.3888.6 –3.08122.0 –56.7872.5
COWA 1.9810.8 5.088.1 0.988.5 3.688.8
Visuospatial and constructional abilities
CD –0.581.7 –1.382.3 0.882.0a –0.782.9
V alues are presented as means 8 SD. a p < 0.05 versus "T12 in CAS group.
Table 3.  Differences with respect to
T0 values in neuropsychological and 
functional scores after 3 and 12 months 
of follow-up in CEA and CAS groups
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new ischemic lesions (26.3 vs. 14.1% for CAS and CEA 
patients, respectively; http://www.cavatas.com/). Never-
theless, none of these studies has shown a clear negative 
effect on cognition after CAS, the clinical relevance of the 
phenomenon remaining an open issue.
 Only few studies analyzed the cognitive effects of ca-
rotid percutaneous transluminal angioplasty (PTA) pro-
cedures or CAS, three of which being in comparison with 
CEA. As for CEA, results of the studies conducted on 
PTA/CAS do not provide us with clear conclusions due to 
their small patient samples and lack of controls  [28] .
 The three studies directly comparing PTA/CAS  [30, 
31, 33] with CEA were performed within the random-
ized controlled Carotid and Vertebral Artery Translu-
minal Angioplasty Study (CAVATAS) and Stent-Pro-
tected Angioplasty versus Carotid Endarterectomy 
(SPACE) study, and one  [31] has been presented only as 
an abstract. In 2000, Crawley et al.  [30] published the 
results of a study performed on two matched subgroups 
of patients randomized in the CAVATAS to undergo 
CEA or PTA, showing that the latter is not associated 
with greater neuropsychological impairment than CEA 
despite the greater incidence of microembolism during 
PTA. Similar to our results, but with a shorter follow-up 
period of 6 and 30 days after treatment, Witt et al.  [33] 
showed no significant differences in neuropsychologi-
cal performances – including verbal and nonverbal 
memory, concentration, visuospatial abilities, verbal 
fluency, cognitive flexibility and motor tasks – between 
patients enrolled in the SPACE study undergoing CEA 
or CAS.
 However, the two large randomized clinical trials CA-
VATAS and SPACE were carried out on subjects with 
symptomatic carotid artery stenosis, while in our study, 
we evaluated a group of subjects with asymptomatic ste-
nosis. Thus, the comparison of those with our results is 
flawed by the difference in study design and patient selec-
tion, particularly because it is possible that subjects with 
symptomatic carotid artery stenosis may already be cog-
nitively impaired due to a previous stroke or transient 
ischemic attack. 
 As revealed by a recent review, neither CEA nor CAS 
appears to clearly affect cognition  [28] , and either cogni-
tive impairment or improvement has been reported after 
either CEA or CAS. In the absence of a control group, it 
is difficult to disentangle whether the progression of cog-
nitive decline after carotid reopening is due to the pro-
gression of the cerebrovascular disease or due to the long-
term consequences of the surgical treatment. A study in-
cluding controls with ACAS is needed to clarify whether 
carotid reopening can avoid, delay the onset or delay the 
progression of cognitive decline.
 Particular strengths of the present study are the rela-
tively lengthy follow-up period for cognitive evaluation 
and the use of several neuropsychological tests to evalu-
ate different cognitive domains. We found no substantial 
differences in cognitive performance including memory, 
attention, and executive and visuospatial/constructional 
abilities in patients undergoing either CEA or CAS. Nei-
ther CEA nor CAS appears to significantly affect cogni-
tive functioning in elderly patients three or twelve months 
after carotid revascularization. As atherosclerosis is a 
progressive disorder, we can speculate that stability of 
cognitive functions could be considered a positive out-
come in subjects who are at a high risk of progression of 
cerebrovascular lesions. Major limitations of this study 
are the small sample size, with inherent implications for 
statistical power, the nonrandomized design and the lack 
of a control group to compare the cognitive modifications 
along time, although both treated groups were cognitive-
ly normal at baseline and remained so during the follow-
up.
 Cerebrovascular pathological changes are recognized 
as important contributors to the onset of cognitive de-
cline and dementia, especially at advanced age  [34] . The 
prevention of cerebrovascular pathological changes may 
contribute to delay dementia onset and progression, thus 
CEA and CAS could represent important therapeutic 
strategies for the prevention of cognitive decline and de-
mentia in the elderly.
 Although CAS, as opposed to CEA, is found to be as-
sociated with a significantly greater incidence of new 
DWI lesions both inside and outside the treated artery 
territory, at this time there is no evidence that this great-
er amount of ischemic burden may be reflected in a high-
er percentage worsening of mortality  [36] or cognition. 
Results from ongoing randomized clinical trials analyz-
ing cognition after CAS versus CEA and the use of a bat-
tery of tests that probably can detect more subtle altera-
tions in vascular cognitive impairment  [37] could clarify 
which benefit or danger, if any, might be expected from 
CAS and CEA in the neuropsychological outcome of pa-
tients with carotid stenosis.
 In conclusion, we did not find significant differences 
in cognitive, mood and functional measures between 
CEA and CAS. Due to these negative results and the non-
randomized design of our study, we cannot infer any 
causal relationship or effects that would allow suggesting 
CEA or CAS as the treatment of choice for elderly pa-
tients with ACAS. Since the safety of CAS compared to 
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CEA is still under debate  [38] , further studies with a larg-
er number of old and oldest old subjects and with a lon-
ger follow-up, as well as studies using a control group are 
needed to better understand the cost-effectiveness of 
both treatments.
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